Precision Biosciences Inc
DTIL· Nasdaq
DTILPrecision Biosciences Inc
Filed Nov 12, 2019 · 10-Q · 43 days after period end · 0001564590-19-042519
| Metric | Q3 2019 | Q3 2018 |
|---|---|---|
| Revenue | $4.87M | $2.54M |
| Net Income | -$20.74M | -$9.76M |
| EPS Diluted | -$0.41 | -$0.62 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
ended Sep 30, 2019 · filed Nov 12, 2019 · 43 d after period end
